D-Biotin Thalidomide PEG（D-biotin-peg-thalidomide） is a compound that belongs to the class of biotinylated drugs. It is a derivative of thalidomide, a drug initially developed as a sedative but later found to have immunomodulatory and anti-inflammatory properties. D-biotin-peg-thalidomide contains three functional groups: a biotin moiety, a polyethylene glycol (PEG) linker, and a thalidomide molecule.
The biotin moiety, also known as vitamin H, is a water-soluble B vitamin that is essential for various metabolic processes in the body. The PEG linker provides stability and solubility to the compound, allowing for better pharmacokinetics and drug delivery. Thalidomide, on the other hand, is known for its immunomodulatory and anti-inflammatory properties, making it a promising drug candidate for various diseases, including cancer, autoimmune disorders, and infectious diseases.
D-biotin-peg-thalidomide has gained attention in drug research and development due to its potential applications in targeted drug delivery and imaging. The biotin moiety allows for specific binding to biotin receptors that are overexpressed in certain cancers and inflammatory conditions, enabling targeted drug delivery to diseased cells. Additionally, the biotin moiety can be used for imaging purposes, allowing for non-invasive detection and monitoring of diseases.
D-Biotin Thalidomide PEG